Subscribe To

Price Alert Latest News Economic Calendar News

DXCM / Is Dexcom a Good Stock to Buy Now?

Dexcom recently reported results from the first quarter of 2023 and reactions were mixed. Wall Street analysts cheered but shares of Dexcom fell a couple of percentage points. Read More

Demo Live Account See Partner Details

Content Topics

DXCM

Posted: May 2 2023, 05:14

Author Name: The Motley Fool

DXCM News

By The Motley Fool
November 2, 2023

2 Growth Stocks That Could Help Set You Up for Life

Healthcare and e-commerce are two massive, lucrative industries that aren't slowing down. DexCom is riding on a wave of profits and cash from its late

By Zacks Investment Research
October 31, 2023

3 Reasons Growth Investors Will Love DexCom (DXCM)

DexCom (DXCM) is well positioned to outperform the market, as it exhibits above-average growth in financials.

By Zacks Investment Research
October 31, 2023

What Makes DexCom (DXCM) a New Buy Stock

DexCom (DXCM) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

By CNBC Television
October 27, 2023

Dexcom stock climbs as worries surrounding weight-loss drugs fades

CNBC's Angelica Peebles joins 'Closing Bell Overtime' to take a closer look at stock movers in the healthcare sector.

By Barrons
October 27, 2023

Dexcom Stock Soars on Earnings. Ozempic Isn't the Threat It Was Supposed to Be

The maker of continuous glucose monitoring devices said there was no sign weight-loss drugs were hurting demand for its products.

By Zacks Investment Research
October 27, 2023

DexCom (DXCM) Beats on Q3 Earnings, Raises Sales Outlook

DexCom's (DXCM) third-quarter 2023 results reflect strong domestic and international revenue growth on the back of its real-time Continuous Glucose Mo

By Seeking Alpha
October 26, 2023

Dexcom, Inc. (DXCM) Q3 2023 Earnings Call Transcript

Dexcom, Inc. (NASDAQ:DXCM ) Q3 2023 Earnings Conference Call October 26, 2023 4:30 PM ET Company Participants Sean Christensen - Director, Corporate A

By Zacks Investment Research
October 26, 2023

DexCom (DXCM) Reports Q3 Earnings: What Key Metrics Have to Say

The headline numbers for DexCom (DXCM) give insight into how the company performed in the quarter ended September 2023, but it may be worthwhile to co

Risk Disclosure:

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
We would like to remind you that the data contained in this website is not necessarily real-time nor accurate.
The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. We and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of us and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. We may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.